Trial intelligence / Profile preview

Ketamine for Sedation in Flexible Bronchoscopy

NCT06181188Phase 4Completed

Sponsor
Brooke Army Medical Center
Start
Jul 2019
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of ketamine (2 arms), sponsored by Brooke Army Medical Center. Primary endpoint: Patient sedation satisfaction with sedation instrument. Started Jul 2019; status: completed.

02

Drugs

ketamine

Beyond the preview

Go deeper on NCT06181188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06181188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call